SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India
PLOS Neglected Tropical Diseases·
- DOI
- 10.1371/journal.pntd.0012918
- PMID
- 40063870
- PMCID
- PMC11922521
- OpenAlex
- W4408289046
- Study type
- Journal article
- Publisher
- Public Library of Science (PLoS)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The paper presents characterization of viral substitution patterns across demographic, geographic, and vaccination-period categories as relevant to ongoing monitoring of SARS-CoV-2 evolution and pandemic preparedness. These implications are based on the study's reported genomic patterns and do not establish causal effects or confirm a current surveillance signal.
Structured evidence summary
Research question
The study examines how SARS-CoV-2 substitution patterns vary by age group, geographic location, vaccination period, and variant wave within India.
Study design
This is a bioinformatic and statistical analysis of SARS-CoV-2 genomic data from GISAID. The analysis used a balanced dataset of 69,975 samples divided equally among children, working-age adults, and elderly individuals, covering the Alpha, Delta, and Omicron waves and different vaccination-period contexts.
Population and setting
The study concerns SARS-CoV-2 samples from the Indian population, categorized as children aged 1-17 years, adults aged 18-64 years, and adults aged 65 years or older. It also evaluates geographic differences within India.
Main findings
The working-age group had a higher frequency of unique substitutions than the other age groups. The abstract also reports geographic variation in substitution rates and higher substitution levels during and after the vaccination period than before it, including changes in ORF1ab and Spike regions.
Public-health relevance
The paper presents characterization of viral substitution patterns across demographic, geographic, and vaccination-period categories as relevant to ongoing monitoring of SARS-CoV-2 evolution and pandemic preparedness. These implications are based on the study's reported genomic patterns and do not establish causal effects or confirm a current surveillance signal.
Important limitations
The supplied abstract does not describe the genomic sampling strategy, representativeness of the GISAID data, or methods for addressing confounding between age, geography, sampling time, vaccination status, and variant wave. This summary is limited to the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation.
GIDS interpretation
The article is discoverable in a GIDS context because it uses GISAID genomic data and addresses SARS-CoV-2 evolution, geographic variation, vaccination-period comparisons, and surveillance-related topics in India. The supplied evidence does not support linking its findings to a live surveillance signal or treating the paper as confirmation of current trends.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 14 auditable classifier relationships to diseases, places, topics, and study design.